ScholarLens Back to search
2010•European Journal of Clinical PharmacologyOpen access

VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement

Helene Puehringer, Ralph M. Loreth, Gudrun Klose, Brigitte Schreyer, Walter Krugluger, Barbara Schneider, Christian Oberkanins

Open full text 26 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 26 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Phenprocoumon, VKORC1, Acenocoumarol, CYP2C9, Vitamin K epoxide reductase, Warfarin, Internal medicine, Pharmacogenetics

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
VKORC1 −1639G>A and CYP2C9*3 are the major genetic predictors of phenprocoumon dose requirement — Research Paper | ScholarLens